Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22173143 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Interchangeability of Infanrix™ IPV/Hib and Pediacel® at 2,4 & 6 Months of Age
Condition: Infant Immunizations
Intervention: Biological: Pediacel® and Infanrix™-IPV/Hib

Indicates status has not been verified in more than two years